Buckingham Capital Management (New York)’s Boston Scientific BSX Stock Holding History

Buckingham Capital Management (New York)’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-358,188	Closed	-$8.37M	–	93
2016 Q2	$8.37M	Sell	358,188 -288,900	-45%	-$6.25M	1.02%	36
2016 Q1	$12.2M	Sell	647,088 -9,042	-1%	-$159K	1.38%	29
2015 Q4	$12.1M	Sell	656,130 -27,494	-4%	-$493K	1.5%	23
2015 Q3	$11.2M	Buy	683,624 +133,438	+24%	+$2.28M	1.02%	40
2015 Q2	$9.74M	Sell	550,186 -1,391	-0.3%	-$24.9K	0.81%	52
2015 Q1	$9.79M	Buy	551,577 +37,420	+7%	+$591K	0.85%	50
2014 Q4	$6.81M	Buy	514,157 +125,790	+32%	+$1.61M	0.6%	57
2014 Q3	$4.59M	Buy	+388,367	New	+$4.89M	0.41%	86

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Buckingham Capital Management (New York)'s BSX Position: Q3 2016 in Review

Buckingham Capital Management (New York) sold out of Boston Scientific (BSX) in Q3 2016, closing a stake of 358,188 shares — an estimated $8.37M sold.

Buckingham Capital Management (New York) first reported a position in BSX in Q3 2014 and held it in 8 quarters. The position peaked at $12.2M in Q1 2016. 568 funds tracked by Wall St. Rank hold BSX as of Q3 2016.

Buckingham Capital Management (New York) reported no remaining Boston Scientific position as of Q3 2016 after selling out during the quarter.
Buckingham Capital Management (New York) sold 358,188 Boston Scientific shares in Q3 2016, an estimated $8.37M.
Buckingham Capital Management (New York) first reported a position in Boston Scientific in Q3 2014 and held it in 8 quarters.
Buckingham Capital Management (New York)'s Boston Scientific position peaked at $12.2M in Q1 2016.
568 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2016.

Based on Buckingham Capital Management (New York)'s 13F filing for Q3 2016, filed 27 Oct 2016.